Pason Systems Inc. (PSYTF)
USD 9.3
(-1.48%)
USD 9.3
(-1.48%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 135.03 Million | 104.41 Million | 65.06 Million | 58.58 Million | 108.54 Million | 107.17 Million |
| Net Income | 97.53 Million | 105.72 Million | 31.92 Million | 5.13 Million | 53.8 Million | 62.94 Million |
| Depreciation & Amortization | 27.21 Million | 20.84 Million | 25.68 Million | 34.41 Million | 40.83 Million | 34.85 Million |
| Deferred income taxes | 5.21 Million | 896 Thousand | -2.13 Million | -467 Thousand | 2.18 Million | 9.79 Million |
| Stock-based compensation | 11.71 Million | 15.23 Million | 11.52 Million | 4.84 Million | 10.84 Million | 12.31 Million |
| Change in working capital | 6.97 Million | 1.67 Million | 4.34 Million | 25.3 Million | 14.19 Million | -5.31 Million |
| Other non-cash items | -13.63 Million | -39.95 Million | -6.28 Million | -10.64 Million | -13.3 Million | -7.41 Million |
| Investing Cash Flow | -13.06 Million | -92.23 Million | -27.07 Million | -12.27 Million | -56.25 Million | -21.84 Million |
| Investments in PPE | -40.91 Million | -34.5 Million | -10.92 Million | -5.15 Million | -24.17 Million | -23.87 Million |
| Acquisitions | 2.76 Million | 874 Thousand | 1.13 Million | -2.56 Million | -23.66 Million | -2.92 Million |
| Investment purchases | -15.44 Million | -58.29 Million | -17.12 Million | -5 Million | -10 Million | -65.84 Million |
| Sales/Maturities of investments | 40.37 Million | -874 Thousand | -1.13 Million | 953 Thousand | 1.32 Million | 65.65 Million |
| Other Investing Activities | 144 Thousand | 562 Thousand | 970 Thousand | -513 Thousand | 263 Thousand | 5.14 Million |
| Financing Cash Flow | -65.81 Million | -42.06 Million | -27.04 Million | -52.19 Million | -86.11 Million | -49.69 Million |
| Debt repayment | -2.27 Million | -1.82 Million | -2.19 Million | -2.29 Million | -2.34 Million | - |
| Dividends payments | -38.53 Million | -29.47 Million | -16.56 Million | -40.42 Million | -63.1 Million | -59.78 Million |
| Common Stock Repurchased | -27.93 Million | -13.78 Million | -8.43 Million | -9.47 Million | -24.04 Million | -921 Thousand |
| Common Stock Issuance | 2.92 Million | 3.01 Million | 146 Thousand | - | 3.36 Million | 11.01 Million |
| Other Financing Activities | 2.92 Million | 3.01 Million | 146 Thousand | - | 3.36 Million | 11.01 Million |
| Accounts receivables | 18.81 Million | -35.36 Million | -5.96 Million | 39.4 Million | 23.26 Million | -10.46 Million |
| Accounts payables | -20.82 Million | 11.73 Million | 11.21 Million | -15.09 Million | -8.54 Million | 4.36 Million |
| Inventory | -2.22 Million | -10.92 Million | 5.96 Million | -39.4 Million | -23.26 Million | - |
| Other working capital | 11.2 Million | 36.22 Million | -6.87 Million | 40.4 Million | 22.73 Million | -9.68 Million |
| Cash at beginning of period | 132.05 Million | 158.28 Million | 149.28 Million | 161.01 Million | 203.83 Million | 154.12 Million |
| Cash at end of period | 171.77 Million | 132.05 Million | 158.28 Million | 149.28 Million | 161.01 Million | 203.83 Million |
| Capital Expenditure | -40.91 Million | -34.5 Million | -10.92 Million | -5.15 Million | -24.17 Million | -23.87 Million |
| Effect of forex changes on cash | -16.43 Million | 3.65 Million | -1.93 Million | -5.84 Million | -9 Million | 14.07 Million |
| Net cash flow / Change in cash | 39.71 Million | -26.22 Million | 9 Million | -11.73 Million | -42.82 Million | 49.7 Million |
| Free Cash Flow | 94.12 Million | 69.91 Million | 54.14 Million | 53.42 Million | 84.36 Million | 83.3 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 10.89 Million | 69.52 Million | 97.53 Million | 8.49 Million | 27.39 Million | 24.96 Million |
| Depreciation & Amortization | 12.9 Million | 11.73 Million | 27.21 Million | 7.79 Million | 6.98 Million | 5.81 Million |
| Deferred income taxes | 1.39 Million | 1.53 Million | 5.21 Million | 501 Thousand | 799 Thousand | 565 Thousand |
| Stock-based compensation | 4.63 Million | 3.01 Million | 11.71 Million | 4.73 Million | 5.08 Million | 1.98 Million |
| Change in working capital | 3.46 Million | -1.99 Million | 6.97 Million | -3.08 Million | -3.64 Million | 5.82 Million |
| Other non-cash items | 24.3 Million | -15.4 Million | -13.63 Million | 8.97 Million | -4.92 Million | -9.49 Million |
| Investing Cash Flow | -17.94 Million | -106.57 Million | -13.06 Million | 27.28 Million | -11.68 Million | -16.67 Million |
| Investments in PPE | -18.32 Million | -20.07 Million | -40.91 Million | -9.95 Million | -6.8 Million | -12.48 Million |
| Acquisitions | 317 Thousand | -71.92 Million | 2.76 Million | 1.72 Million | -5 Million | -5 Million |
| Investment purchases | - | -4.18 Million | -15.44 Million | -5 Million | -5 Million | -5 Million |
| Sales/Maturities of investments | - | - | 40.37 Million | 40.37 Million | 5 Million | 5 Million |
| Other Investing Activities | 66 Thousand | -10.39 Million | 144 Thousand | 127 Thousand | 125 Thousand | 813 Thousand |
| Financing Cash Flow | -10.49 Million | -27.13 Million | -65.81 Million | -12.39 Million | -16.09 Million | -17.36 Million |
| Debt repayment | -934 Thousand | -13.26 Million | -2.27 Million | -344 Thousand | -580 Thousand | -787 Thousand |
| Dividends payments | -10.37 Million | -10.33 Million | -38.53 Million | -9.55 Million | -9.6 Million | -9.63 Million |
| Common Stock Repurchased | -2.7 Million | -3.29 Million | -27.93 Million | -4.99 Million | -5.95 Million | -6.99 Million |
| Common Stock Issuance | 3.51 Million | 515 Thousand | 2.92 Million | 2.49 Million | 46 Thousand | 43 Thousand |
| Other Financing Activities | 3.51 Million | 515 Thousand | 2.92 Million | 2.49 Million | 46 Thousand | 43 Thousand |
| Accounts receivables | 6.18 Million | -13.41 Million | 18.81 Million | 8.37 Million | -1.82 Million | 14.58 Million |
| Accounts payables | -5.73 Million | 1.44 Million | -20.82 Million | -9.14 Million | -3.32 Million | -6.84 Million |
| Inventory | -1.63 Million | 1.04 Million | -2.22 Million | 823 Thousand | -425 Thousand | -489 Thousand |
| Other working capital | 4.64 Million | 8.94 Million | 11.2 Million | -3.13 Million | 1.93 Million | -1.42 Million |
| Cash at beginning of period | 70.05 Million | 171.77 Million | 132.05 Million | 138.35 Million | 134.72 Million | 144.35 Million |
| Cash at end of period | 66.81 Million | 70.05 Million | 171.77 Million | 171.77 Million | 138.35 Million | 134.72 Million |
| Capital Expenditure | -18.32 Million | -20.07 Million | -40.91 Million | -9.95 Million | -6.8 Million | -12.48 Million |
| Effect of forex changes on cash | -772 Thousand | 977 Thousand | -16.43 Million | -8.88 Million | -287 Thousand | -5.25 Million |
| Net cash flow / Change in cash | -3.23 Million | -101.72 Million | 39.71 Million | 33.41 Million | 3.63 Million | -9.63 Million |
| Free Cash Flow | 7.64 Million | 10.93 Million | 94.12 Million | 17.46 Million | 24.89 Million | 17.17 Million |
300056
BAFN
PHARMAID
DEVIT
T
UNIINFO